| Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties S Schwitalla, AA Fingerle, P Cammareri, T Nebelsiek, SI Göktuna, ... Cell 152 (1), 25-38, 2013 | 1207 | 2013 |
| Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis M Strunz, LM Simon, M Ansari, JJ Kathiriya, I Angelidis, CH Mayr, ... Nature communications 11 (1), 3559, 2020 | 530 | 2020 |
| Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer J Neumann, E Zeindl-Eberhart, T Kirchner, A Jung Pathology-Research and Practice 205 (12), 858-862, 2009 | 469 | 2009 |
| β2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer BW Renz, R Takahashi, T Tanaka, M Macchini, Y Hayakawa, Z Dantes, ... Cancer cell 33 (1), 75-90. e7, 2018 | 442 | 2018 |
| Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis T Jamieson, M Clarke, CW Steele, MS Samuel, J Neumann, A Jung, ... The Journal of clinical investigation 122 (9), 3127-3144, 2012 | 408 | 2012 |
| Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread E Pretzsch, F Bösch, J Neumann, P Ganschow, A Bazhin, M Guba, ... Journal of oncology 2019 (1), 7407190, 2019 | 293 | 2019 |
| The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer D Horst, SK Scheel, S Liebmann, J Neumann, S Maatz, T Kirchner, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 239 | 2009 |
| SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer J Neumann, F Bahr, D Horst, L Kriegl, J Engel, R Mejías-Luque, ... BMC cancer 11, 1-7, 2011 | 193 | 2011 |
| Detection of miR-34a Promoter Methylation in Combination with Elevated Expression of c-Met and β-Catenin Predicts Distant Metastasis of Colon Cancer H Siemens, J Neumann, R Jackstadt, U Mansmann, D Horst, T Kirchner, ... Clinical cancer research 19 (3), 710-720, 2013 | 181 | 2013 |
| AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer R Jackstadt, S Röh, J Neumann, P Jung, R Hoffmann, D Horst, C Berens, ... Journal of Experimental Medicine 210 (7), 1331-1350, 2013 | 170 | 2013 |
| Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer A Herbst, K Rahmig, P Stieber, A Philipp, A Jung, A Ofner, A Crispin, ... Official journal of the American College of Gastroenterology| ACG 106 (6 …, 2011 | 135 | 2011 |
| FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer–subgroup analysis of patients with KRAS: mutated … S Stintzing, LF von Weikersthal, T Decker, U Vehling-Kaiser, E Jäger, ... Annals of oncology 23 (7), 1693-1699, 2012 | 125 | 2012 |
| Should ALPPS be used for liver resection in intermediate-stage HCC? JG D’Haese, J Neumann, M Weniger, S Pratschke, B Björnsson, V Ardiles, ... Annals of surgical oncology 23, 1335-1343, 2016 | 124 | 2016 |
| Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status DP Modest, S Stintzing, RP Laubender, J Neumann, A Jung, C Giessen, ... Anti-cancer drugs 22 (9), 913-918, 2011 | 124 | 2011 |
| Up and downregulation of p16Ink4a expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer L Kriegl, J Neumann, M Vieth, FR Greten, S Reu, A Jung, T Kirchner Modern Pathology 24 (7), 1015-1022, 2011 | 119 | 2011 |
| EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104 S Boeck, A Jung, RP Laubender, J Neumann, R Egg, C Goritschan, ... British journal of cancer 108 (2), 469-476, 2013 | 117 | 2013 |
| Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal … S Stintzing, C Kapaun, RP Laubender, A Jung, J Neumann, DP Modest, ... International journal of cancer 132 (1), 236-245, 2013 | 108 | 2013 |
| Prognostic role of methylated free circulating DNA in colorectal cancer AB Philipp, P Stieber, D Nagel, J Neumann, F Spelsberg, A Jung, ... International journal of cancer 131 (10), 2308-2319, 2012 | 104 | 2012 |
| KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer S Boeck, A Jung, RP Laubender, J Neumann, R Egg, C Goritschan, ... Journal of gastroenterology 48, 544-548, 2013 | 93 | 2013 |
| Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater TS Schiergens, S Reu, J Neumann, BW Renz, H Niess, S Boeck, ... Surgery 158 (1), 151-161, 2015 | 85 | 2015 |
Andreas JungProfessor for Molecular Pathology, University of MunichVerificeret mail på lmu.de
